Evaluation of the Cryocheck HexLA Integrated TCA for the Detection of Lupus Anticoagulant

Recruiting Observational Study
Lupus Anticoagulant
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
200 (estimated)
Sponsor
University Hospital, Strasbourg, France · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Lupus anticoagulant (LA) testing is performed using two screening tests: activated partial thromboplastin time (APTT) and diluted Russell's viper venom time. If one of the screening tests is positive, a confirmation test based on the same principle is performed. The HUS Hematology Laboratory uses an integrated APTT for LA testing, consisting of a screening reagent: Cephen LS, and a confirmation r…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient of legal age (≥ 18 years) * Sample sent to the HUS Hematology Laboratory and analyzed for LA detection as part of routine care. Exclusion Criteria: \- Insufficient sample volume
Contacts

Agathe HERB, PharmD

33 3 88 12 75 53

agathe.herb@chru-strasbourg.fr

CONTACT